Vertex price target lowered to $535 from $600 at H.C. Wainwright

Dec 20, 2024 · H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $535 from $600 and keeps a Buy rating on the shares after the …

$535
OFF

Vertex Price Target Lowered To $535 From $600 At H.C. Wainwright

4 weeks from now

Dec 20, 2024 · H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $535 from $600 and keeps a Buy rating on the shares after the …

nasdaq.com

$600.00
OFF

HC Wainwright Has Lowered Expectations For Vertex ... - MarketBeat

4 weeks from now

Dec 20, 2024 · HC Wainwright decreased their price objective on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating for the company in a report …

marketbeat.com

$600.00
OFF

HC Wainwright Has Lowered Expectations For Vertex …

4 weeks from now

Dec 22, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price reduced by equities research analysts at HC Wainwright from $600.00 to $535.00 in a …

defenseworld.net

$600.00
OFF

HC Wainwright Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) …

4 weeks from now

Dec 22, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price reduced by stock analysts at HC Wainwright from $600.00 to $535.00 in a research report …

etfdailynews.com

$500.00
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $500.00 Price …

4 weeks from now

Dec 23, 2024 · HC Wainwright lowered their price objective on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating on the stock in a research report on Friday. …

marketbeat.com

$535
OFF

HC Wainwright Adjusts Vertex Pharmaceuticals Price Target To …

4 weeks from now

Dec 20, 2024 · Low valuations. My Screeners. All my stocks. Watchlists. Virtual Portfolios. Tools. ... HC Wainwright Adjusts Vertex Pharmaceuticals Price Target to $535 From $600, Maintains …

marketscreener.com

$566.00
OFF

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives …

4 weeks from now

9 hours ago · BMO Capital Markets lowered their price target on Vertex Pharmaceuticals from $566.00 to $520.00 and set an "outperform" rating for the company in a research note on …

marketbeat.com

$600.00
OFF

Vertex Shares Price Target Cut, Holds Buy Rating On Trial's Findings

4 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright adjusted its stock price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX), reducing it from $600.00 …

investing.com

$600.00
OFF

Vertex Shares Price Target Cut, Holds Buy Rating On Trial's Findings

4 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright adjusted its stock price target for Vertex Pharmaceuticals (NASDAQ: VRTX) Incorporated (NASDAQ:VRTX), reducing it from $600.00 …

investing.com

50%
OFF

Vertex Pharmaceuticals Analyst Ratings - Stock Analysis

4 weeks from now

17 hours ago · Price Target . $507.72. Upside +26.50%. Ratings History. Columns. Filter results. Columns. Analyst Performance. Analyst Firm ... HC Wainwright & Co. HC Wainwright & Co. …

stockanalysis.com

$600.00
OFF

HC Wainwright Issues Pessimistic Forecast For Vertex …

4 weeks from now

Dec 23, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective cut by HC Wainwright from $600.00 to $535.00 in a research note released on Friday, …

americanbankingnews.com

$600.00
OFF

BMO Capital Markets Has Lowered Expectations For Vertex …

4 weeks from now

Dec 22, 2024 · HC Wainwright lowered their price target on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a “buy” rating for the company in a report on Friday.

defenseworld.net

$535.00
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Stock, Analyst Ratings, …

4 weeks from now

The latest price target for Vertex Pharmaceuticals (NASDAQ:VRTX) was reported by HC Wainwright & Co. on December 20, 2024. The analyst firm set a price target for $535.00 …

benzinga.com

$600.00
OFF

Vertex Pharmaceuticals (VRTX) News Today - MarketBeat

4 weeks from now

5 days ago · HC Wainwright decreased their price objective on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating for the company in a report on Friday. ... Bank …

marketbeat.com

$600.00
OFF

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives …

4 weeks from now

9 hours ago · Finally, HC Wainwright cut their target price on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a “buy” rating on the stock in a report on Friday, December …

defenseworld.net

$600.00
OFF

Barclays Has Lowered Expectations For Vertex ... - MarketBeat

4 weeks from now

Dec 20, 2024 · HC Wainwright decreased their price objective on Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating on the stock in a research report on Friday. Morgan …

marketbeat.com

$600.00
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut To …

4 weeks from now

Dec 24, 2024 · HC Wainwright dropped their price objective on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a “buy” rating on the stock in a research report on Friday.

defenseworld.net

$600.00
OFF

Zacks Research Has Positive Estimate For VRTX Q3 Earnings

4 weeks from now

5 days ago · HC Wainwright dropped their price objective on Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating for the company in a report on Friday, December …

marketbeat.com

88%
OFF

Vertex Pharmaceuticals (VRTX) Stock Forecast & Price Target

4 weeks from now

HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating : Lower Target: Buy Buy: $600.00 $535.00 +34.88%: ... the average twelve-month stock price …

marketbeat.com

FAQs about Vertex price target lowered to $535 from $600 at H.C. Wainwright Coupon?

Should you buy Vertex Pharmaceuticals (VRTX) stock?

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price reduced by stock analysts at HC Wainwright from $600.00 to $535.00 in a research report issued on Friday, Marketbeat.com reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. ...

Is Vertex Pharmaceuticals a good stock to buy?

Jefferies Financial Group raised Vertex Pharmaceuticals from a “hold” rating to a “buy” rating and raised their price target for the stock from $500.00 to $550.00 in a research report on Monday, December 9th. ...

How do I receive news & ratings for Vertex Pharmaceuticals?

Receive News & Ratings for Vertex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter. ...

Who owns Vertex Pharmaceuticals?

Finally, Stephens Consulting LLC bought a new stake in Vertex Pharmaceuticals in the 2nd quarter valued at $31,000. 90.96% of the stock is currently owned by institutional investors and hedge funds. (Get Free Report) ...

What is the consensus rating for Vertex Pharmaceuticals?

The consensus rating score for Vertex Pharmaceuticals is 2.52 while the average consensus rating score for "medical" companies is 2.81. Learn more on how VRTX compares to other companies. Porter Stansberry’s latest video is going viral… ...

Does Vertex Pharmaceuticals Incorporated have a good debt-to-equity ratio?

Vertex Pharmaceuticals Incorporated maintains a low debt-to-equity ratio of 0.01, indicating a strong balance sheet and reduced financial risk, which is attractive to conservative investors. ...